NC
OFIX icon

nVerses Capital’s Orthofix Medical OFIX Stock Holding History

nVerses Capital’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+12,391
New +$137K 0.17% 238
2024
Q4 		– Sell
-1,900
Closed -$29.7K – 602
2024
Q3 		$29.7K Sell
1,900
-100
-5% -$1.6K 0.01% 746
2024
Q2 		$26.5K Buy
+2,000
New +$27.4K 0.02% 724

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

nVerses Capital's OFIX Position: Q2 2026 in Review

nVerses Capital opened a new position in Orthofix Medical (OFIX) in Q2 2026: 12,391 shares worth $113K. The stake represents 0.17% of the portfolio and ranks #238 among its holdings. This is a return to the name: nVerses Capital previously reported a position in OFIX as recently as Q3 2024.

nVerses Capital first reported a position in OFIX in Q2 2024 and has held it in 3 quarters since. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • nVerses Capital held 12,391 shares of Orthofix Medical worth $113K as of Q2 2026.
  • Orthofix Medical was a new nVerses Capital position in Q2 2026.
  • Orthofix Medical made up 0.17% of nVerses Capital's portfolio in Q2 2026, its #238 holding.
  • nVerses Capital first reported a position in Orthofix Medical in Q2 2024 and has held it in 3 quarters since.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.